JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 51 filers reported holding JANUX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,342,236 | -15.3% | 331,571 | -0.3% | 0.00% | – |
| Q2 2023 | $3,947,843 | +9.3% | 332,590 | +11.4% | 0.00% | – |
| Q1 2023 | $3,613,411 | -51.5% | 298,629 | -47.3% | 0.00% | – |
| Q4 2022 | $7,457,118 | +108.5% | 566,220 | +114.3% | 0.00% | – |
| Q3 2022 | $3,577,000 | +10.9% | 264,207 | +0.1% | 0.00% | – |
| Q2 2022 | $3,224,000 | -7.1% | 264,022 | +9.1% | 0.00% | – |
| Q1 2022 | $3,470,000 | -16.9% | 241,998 | +14.4% | 0.00% | – |
| Q4 2021 | $4,174,000 | +10.5% | 211,566 | +21.1% | 0.00% | – |
| Q3 2021 | $3,778,000 | – | 174,644 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 8,670,644 | $104,914,792 | 2.38% |
| EcoR1 Capital, LLC | 3,838,486 | $46,445,681 | 1.50% |
| Samsara BioCapital, LLC | 360,414 | $4,361,009 | 0.90% |
| BVF INC/IL | 1,585,677 | $19,186,692 | 0.70% |
| Orbimed Advisors | 2,836,386 | $34,320,271 | 0.67% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,000 | $10,890,000 | 0.02% |
| Woodline Partners LP | 137,300 | $1,661,330 | 0.02% |
| Vident Investment Advisory, LLC | 55,483 | $671,344 | 0.02% |
| JANUS HENDERSON GROUP PLC | 1,869,076 | $22,611,527 | 0.02% |
| FMR LLC | 10,281,288 | $124,403,584 | 0.01% |